QMA

ALX Oncology Holdings Inc. (ALXO) — QMA analysis

Sector: Healthcare · Data as of Nov 4, 2026

Price and market data

39
/100
D
Composite grade
Higher score than 32% of 21,569 securities in the comparison

ALX Oncology Holdings Inc. has a below-average composite score of 39/100, higher score than 32% of 21,569 securities in the comparison. The highest-scoring layer is Analysts / transcripts; the lowest is Catalysts.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.
Share this analysis
𝕏in

What 8 data layers say about ALXO

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)37/100
Technical trend (TSS)31/100
Relative strength (RS)39/100
Momentum (USS)54/100
Insider activity (IAS)22/100
Off-exchange trading (FINRA) / large flows (WHS)52/100
Analysts / transcripts (ATS)89/100
Catalysts (XS)19/100

What does the QMA model currently show for ALX Oncology Holdings Inc.?

The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.

For ALXO the layers diverge — some score high (Analysts / transcripts), others low (Catalysts). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

ALXO insider & smart money activity

Over the recent period we record 0 reported insider purchases and 0 sales for ALXO: no reported insider trades in the period. A description of the data layer, not an instruction.

ALXO seasonality

The historically strong window for ALXO was August 1–28 with a hit rate of 71% and an average move of 21.1% (7 years of history; selected in hindsight, descriptive, not a prediction).

Historical data does not guarantee future results.

How ALXO compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for ALXO stock?

39/100 (grade D) as of Nov 4, 2026, fusing 8 data layers. An analytical score, not advice.

Are insiders buying ALXO stock?

Over the recent period, reported: purchases 0, sales 0. Insider activity: no reported insider trades in the period — a description of reported data, not a trade instruction.

Where can I see live ALXO data?

Price and market data for ALXO are shown on paid plans; the QMA scores and grades on this page are free. Registration is free with no card — trial full access, then the free plan.

Explore more — for free

The ALXO score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.

Free registration, no card — trial full access, then the free plan

Want the full ALXO analysis with all layers and live data? Open ALXO detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: support@quantummarketanalyzer.com